Literature DB >> 9243537

Seven ways to increase power without increasing N.

W B Hansen1, L M Collins.   

Abstract

Many readers of this monograph may wonder why a chapter on statistical power was included. After all, by now the issue of statistical power is in many respects mundane. Everyone knows that statistical power is a central research consideration, and certainly most National Institute on Drug Abuse grantees or prospective grantees understand the importance of including a power analysis in research proposals. However, there is ample evidence that, in practice, prevention researchers are not paying sufficient attention to statistical power. If they were, the findings observed by Hansen (1992) in a recent review of the prevention literature would not have emerged. Hansen (1992) examined statistical power based on 46 cohorts followed longitudinally, using nonparametric assumptions given the subjects' age at posttest and the numbers of subjects. Results of this analysis indicated that, in order for a study to attain 80-percent power for detecting differences between treatment and control groups, the difference between groups at posttest would need to be at least 8 percent (in the best studies) and as much as 16 percent (in the weakest studies). In order for a study to attain 80-percent power for detecting group differences in pre-post change, 22 of the 46 cohorts would have needed relative pre-post reductions of greater than 100 percent. Thirty-three of the 46 cohorts had less than 50-percent power to detect a 50-percent relative reduction in substance use. These results are consistent with other review findings (e.g., Lipsey 1990) that have shown a similar lack of power in a broad range of research topics. Thus, it seems that, although researchers are aware of the importance of statistical power (particularly of the necessity for calculating it when proposing research), they somehow are failing to end up with adequate power in their completed studies. This chapter argues that the failure of many prevention studies to maintain adequate statistical power is due to an overemphasis on sample size (N) as the only, or even the best, way to increase statistical power. It is easy to see how this overemphasis has come about. Sample size is easy to manipulate, has the advantage of being related to power in a straight-forward way, and usually is under the direct control of the researcher, except for limitations imposed by finances or subject availability. Another option for increasing power is to increase the alpha used for hypothesis-testing but, as very few researchers seriously consider significance levels much larger than the traditional .05, this strategy seldom is used. Of course, sample size is important, and the authors of this chapter are not recommending that researchers cease choosing sample sizes carefully. Rather, they argue that researchers should not confine themselves to increasing N to enhance power. It is important to take additional measures to maintain and improve power over and above making sure the initial sample size is sufficient. The authors recommend two general strategies. One strategy involves attempting to maintain the effective initial sample size so that power is not lost needlessly. The other strategy is to take measures to maximize the third factor that determines statistical power: effect size.

Mesh:

Year:  1994        PMID: 9243537

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  9 in total

1.  Statistical power in quantitative diffusion MRI of tumor response: strategies for future studies.

Authors:  Ted K Yanagihara; Benjamin Kennedy; Krishna Surapaneni; Jeffrey N Bruce
Journal:  Acad Radiol       Date:  2011-12-16       Impact factor: 3.173

Review 2.  Maximizing the Yield of Small Samples in Prevention Research: A Review of General Strategies and Best Practices.

Authors:  Cameron R Hopkin; Rick H Hoyle; Nisha C Gottfredson
Journal:  Prev Sci       Date:  2015-10

3.  The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study.

Authors:  Shannon Gwin Mitchell; Robert P Schwartz; Anika A H Alvanzo; Monique S Weisman; Tiffany L Kyle; Eva M Turrigiano; Martha L Gibson; Livangelie Perez; Erin A McClure; Sara Clingerman; Autumn Froias; Danielle R Shandera; Robrina Walker; Dean L Babcock; Genie L Bailey; Gloria M Miele; Lynn E Kunkel; Michael Norton; Maxine L Stitzer
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

4.  Planning for Long-Term Follow-Up: Strategies Learned from Longitudinal Studies.

Authors:  Karl G Hill; Danielle Woodward; Tiffany Woelfel; J David Hawkins; Sara Green
Journal:  Prev Sci       Date:  2016-10

5.  Ten years later: Locating and interviewing children of drug abusers.

Authors:  Kevin P Haggerty; Charles B Fleming; Richard F Catalano; Renee S Petrie; Ronald J Rubin; Mary H Grassley
Journal:  Eval Program Plann       Date:  2007-10-23

6.  Auditory Distraction During Reading: A Bayesian Meta-Analysis of a Continuing Controversy.

Authors:  Martin R Vasilev; Julie A Kirkby; Bernhard Angele
Journal:  Perspect Psychol Sci       Date:  2018-06-29

7.  An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis.

Authors:  Caroline M Barry; Aditi Sabhlok; Victoria C Saba; Alesha D Majors; Julia C Schechter; Erica L Levine; Martin Streicher; Gary G Bennett; Scott H Kollins; Bernard F Fuemmeler
Journal:  JMIR Public Health Surveill       Date:  2019-04-02

Review 8.  Developmental cognitive neuroscience using latent change score models: A tutorial and applications.

Authors:  Rogier A Kievit; Andreas M Brandmaier; Gabriel Ziegler; Anne-Laura van Harmelen; Susanne M M de Mooij; Michael Moutoussis; Ian M Goodyer; Ed Bullmore; Peter B Jones; Peter Fonagy; Ulman Lindenberger; Raymond J Dolan
Journal:  Dev Cogn Neurosci       Date:  2017-11-22       Impact factor: 5.811

Review 9.  Improving practices and inferences in developmental cognitive neuroscience.

Authors:  John C Flournoy; Nandita Vijayakumar; Theresa W Cheng; Danielle Cosme; Jessica E Flannery; Jennifer H Pfeifer
Journal:  Dev Cogn Neurosci       Date:  2020-06-30       Impact factor: 6.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.